상세 보기
Journal of Healthcare Engineering
ISSN
P 2040-2295 E 2040-2309
출판사
Multi Science Publishing
국가
ENGLAND
발행 상태
활성
데이터베이스 수록 정보
DOAJ 2017-2021 (5년)
EMBASE 2016-2020 (5년)
JCR 2012-2019 (8년)
MEDLINE 2016-2021 (6년)
SCIE 2012-2021 (10년)
Scopus 2017-2020 (4년)
SJR 2011-2019 (9년)
전체 8건 중 1번부터 8번까지의 결과를 표시합니다.
2025
Article
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial
- Kang, Jeehoon ;
- Park, Kyung Woo ;
- Han, Jungkyu ;
- Hwang, Doyeon ;
- Yang, Han-mo ;
- ... Lim, Younghyo ;
- 외 19명
- 2025-11
- The Lancet
- ELSEVIER SCIENCE INC
2024
Article
Mental illness media guidelines in South Korea to combat stigma
- Jo, Young Tak ;
- Lee, Haewoo ;
- Lee, Jungsun ;
- Kim, Sung-Wan ;
- Choi, Joonho ;
- 외 2명
- 2024-06
- The Lancet
- ELSEVIER SCIENCE INC
2022
Article
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- Deodhar, Atul ;
- Van den Bosch, Filip ;
- Poddubnyy, Denis ;
- Maksymowych, Walter P. ;
- van der Heijde, Desiree ;
- ... Kim, Tae-Hwan ;
- 외 7명
- 2022-07
- The Lancet
- ELSEVIER SCIENCE INC
2020
Article
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial
- Kim, Hyo-Soo ;
- Kang, Jeehoon ;
- Hwang, Doyeon ;
- Han, Jung-Kyu ;
- Yang, Han-mo ;
- ... Lim, Young-Hyo ;
- 외 8명
- 2020-10
- The Lancet
- ELSEVIER SCIENCE INC
Article
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
- Deodhar, Atul ;
- van der Heijde, Desiree ;
- Gensler, Lianne S. ;
- Kim, Tae-Hwan ;
- Maksymowych, Walter P. ;
- 외 12명
- 2020-01
- The Lancet
- ELSEVIER SCIENCE INC
2019
Article
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
- van der Heijde, Desiree ;
- Song, In-Ho ;
- Pangan, Aileen L. ;
- Deodhar, Atul ;
- Van den Bosch, Filip ;
- ... Kim, Tae-Hwan ;
- 외 7명
- 2019-12
- The Lancet
- ELSEVIER SCIENCE INC
Article
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study
- Ye, Byong Duk ;
- Pesegova, Marina ;
- Alexeeva, Olga ;
- Osipenko, Marina ;
- Lahat, Adi ;
- ... Eun, Chang Soo ;
- 외 14명
- 2019-04
- The Lancet
- ELSEVIER SCIENCE INC
2018
Article
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
- van der Heijde, Desiree ;
- Wei, James Cheng-Chung ;
- Dougados, Maxime ;
- Mease, Philip ;
- Deodhar, Atul ;
- ... Kim, Tae Hwan ;
- 외 10명
- 2018-12
- The Lancet
- Elsevier Science Inc.